Skip to main content
Top
Published in: Tobacco Induced Diseases 1/2014

Open Access 01-12-2014 | Research

Effectiveness of proactive and reactive services at the Swedish National Tobacco Quitline in a randomized trial

Authors: Eva Nohlert, John Öhrvik, Ásgeir R Helgason

Published in: Tobacco Induced Diseases | Issue 1/2014

Login to get access

Abstract

Background

The Swedish National Tobacco Quitline (SNTQ), which has both a proactive and a reactive service, has successfully provided tobacco cessation support since 1998. As there is a demand for an increase in national cessation support, and because the quitline works under funding constraints, it is crucial to identify the most clinically effective and cost-effective service. A randomized controlled trial was performed to compare the effectiveness of the high-intensity proactive service with the low-intensity reactive service at the SNTQ.

Methods

Those who called the SNTQ for smoking or tobacco cessation from February 2009 to September 2010 were randomized to proactive service (even dates) and reactive service (odd dates). Data were collected through postal questionnaires at baseline and after 12 months. Those who replied to the baseline questionnaire constituted the study base. Outcome measures were self-reported point prevalence and 6-month continuous abstinence at the 12-month follow-up. Intention-to-treat (ITT) and responder-only analyses were performed.

Results

The study base consisted of 586 persons, and 59% completed the 12-month follow-up. Neither ITT- nor responder-only analyses showed any differences in outcome between proactive and reactive service. Point prevalence was 27% and continuous abstinence was 21% in analyses treating non-responders as smokers, and 47% and 35%, respectively, in responder-only analyses.

Conclusion

Reactive service may be used as the standard procedure to optimize resource utilization at the SNTQ. However, further research is needed to assess effectiveness in different subgroups of clients.

Trial registration

ClinicalTrials.gov: NCT02085616
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO: WHO Report On The Global Tobacco Epidemic, 2011. 2011, Geneva: World Health Organization (WHO) WHO: WHO Report On The Global Tobacco Epidemic, 2011. 2011, Geneva: World Health Organization (WHO)
2.
go back to reference Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Faith Dorfman S, Froelicher ES, Goldstein MG, Healton CG, Nez Henderson P, Heyman RB, Koh HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Dolan Mullen P, Orleans CT, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers M-E: Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. 2008, Rockville, MD: U.S. Department of Health and Human Service. Public Health Service Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Faith Dorfman S, Froelicher ES, Goldstein MG, Healton CG, Nez Henderson P, Heyman RB, Koh HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Dolan Mullen P, Orleans CT, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers M-E: Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. 2008, Rockville, MD: U.S. Department of Health and Human Service. Public Health Service
3.
go back to reference Helgason AR, Lund KE, Adolfsson J, Axelsson S: Tobacco prevention in Swedish dental care. Community Dent Oral Epidemiol. 2003, 31 (5): 378-385. 10.1034/j.1600-0528.2003.00111.x.CrossRefPubMed Helgason AR, Lund KE, Adolfsson J, Axelsson S: Tobacco prevention in Swedish dental care. Community Dent Oral Epidemiol. 2003, 31 (5): 378-385. 10.1034/j.1600-0528.2003.00111.x.CrossRefPubMed
4.
go back to reference Stead M, Angus K, Holme I, Cohen D, Tait G: Factors influencing European GPs’ engagement in smoking cessation: a multi-country literature review. Br J Gen Pract. 2009, 59 (566): 682-690. 10.3399/bjgp09X454007.PubMedCentralCrossRefPubMed Stead M, Angus K, Holme I, Cohen D, Tait G: Factors influencing European GPs’ engagement in smoking cessation: a multi-country literature review. Br J Gen Pract. 2009, 59 (566): 682-690. 10.3399/bjgp09X454007.PubMedCentralCrossRefPubMed
5.
6.
go back to reference Borland R, Segan CJ: The potential of quitlines to increase smoking cessation. Drug Alcohol Rev. 2006, 25 (1): 73-78. 10.1080/09595230500459537.CrossRefPubMed Borland R, Segan CJ: The potential of quitlines to increase smoking cessation. Drug Alcohol Rev. 2006, 25 (1): 73-78. 10.1080/09595230500459537.CrossRefPubMed
7.
go back to reference Smith SS, Keller PA, Kobinsky KH, Baker TB, Fraser DL, Bush T, Magnusson B, Zbikowski SM, McAfee TA, Fiore MC: Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant. Nicotine Tob Res. 2013, 15 (3): 718-728. 10.1093/ntr/nts186.PubMedCentralCrossRefPubMed Smith SS, Keller PA, Kobinsky KH, Baker TB, Fraser DL, Bush T, Magnusson B, Zbikowski SM, McAfee TA, Fiore MC: Enhancing tobacco quitline effectiveness: identifying a superior pharmacotherapy adjuvant. Nicotine Tob Res. 2013, 15 (3): 718-728. 10.1093/ntr/nts186.PubMedCentralCrossRefPubMed
8.
go back to reference Willemsen MC, van der Meer RM, Bor S: Description, Effectiveness, and Client Satisfaction of 9 European Quitlines: Results of the European Smoking Cessation Helplines Evaluation Project (ESCHER). 2008, Den Haag: STIVORO Willemsen MC, van der Meer RM, Bor S: Description, Effectiveness, and Client Satisfaction of 9 European Quitlines: Results of the European Smoking Cessation Helplines Evaluation Project (ESCHER). 2008, Den Haag: STIVORO
9.
go back to reference Stead LF, Hartmann-Boyce J, Perera R, Lancaster T: Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2013, 8: CD002850 Stead LF, Hartmann-Boyce J, Perera R, Lancaster T: Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2013, 8: CD002850
10.
go back to reference Stead LF, Perera R, Lancaster T: Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2006, 3: CD002850 Stead LF, Perera R, Lancaster T: Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2006, 3: CD002850
11.
go back to reference Ferguson J, Docherty G, Bauld L, Lewis S, Lorgelly P, Boyd KA, McEwen A, Coleman T: Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial. BMJ. 2012, 344: e1696-10.1136/bmj.e1696.PubMedCentralCrossRefPubMed Ferguson J, Docherty G, Bauld L, Lewis S, Lorgelly P, Boyd KA, McEwen A, Coleman T: Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial. BMJ. 2012, 344: e1696-10.1136/bmj.e1696.PubMedCentralCrossRefPubMed
12.
go back to reference Gilbert H, Sutton S: Evaluating the effectiveness of proactive telephone counselling for smoking cessation in a randomized controlled trial. Addiction. 2006, 101 (4): 590-598. 10.1111/j.1360-0443.2006.01398.x.CrossRefPubMed Gilbert H, Sutton S: Evaluating the effectiveness of proactive telephone counselling for smoking cessation in a randomized controlled trial. Addiction. 2006, 101 (4): 590-598. 10.1111/j.1360-0443.2006.01398.x.CrossRefPubMed
13.
14.
go back to reference The National Swedish Board of Health and Welfare and Swedish National Institute of Public Health: Public health in Sweden - Annual report 2013. 2013, Stockholm: The National Swedish Board of Health and Welfare and Swedish National Institute of Public Health The National Swedish Board of Health and Welfare and Swedish National Institute of Public Health: Public health in Sweden - Annual report 2013. 2013, Stockholm: The National Swedish Board of Health and Welfare and Swedish National Institute of Public Health
15.
go back to reference Swedish National Institute of Public Health: Tobacco and Weaning. 2009, Östersund: Swedish National Institute of Public Health Swedish National Institute of Public Health: Tobacco and Weaning. 2009, Östersund: Swedish National Institute of Public Health
16.
go back to reference Helgason AR, Tomson T, Lund KE, Galanti R, Ahnve S, Gilljam H: Factors related to abstinence in a telephone helpline for smoking cessation. Eur J Public Health. 2004, 14 (3): 306-310. 10.1093/eurpub/14.3.306.CrossRefPubMed Helgason AR, Tomson T, Lund KE, Galanti R, Ahnve S, Gilljam H: Factors related to abstinence in a telephone helpline for smoking cessation. Eur J Public Health. 2004, 14 (3): 306-310. 10.1093/eurpub/14.3.306.CrossRefPubMed
17.
go back to reference Tomson T, Helgason AR, Gilljam H: Quitline in smoking cessation: a cost-effectiveness analysis. Int J Technol Assess Health Care. 2004, 20 (4): 469-474.CrossRefPubMed Tomson T, Helgason AR, Gilljam H: Quitline in smoking cessation: a cost-effectiveness analysis. Int J Technol Assess Health Care. 2004, 20 (4): 469-474.CrossRefPubMed
18.
go back to reference Hosmer DW, Lemeshow S: Applied logistic regression. 1989, New York: Wiley Hosmer DW, Lemeshow S: Applied logistic regression. 1989, New York: Wiley
19.
go back to reference Lindqvist H, Forsberg LG, Forsberg L, Rosendahl I, Enebrink P, Helgason AR: Motivational Interviewing in an ordinary clinical setting: a controlled clinical trial at the Swedish National Tobacco Quitline. Addict Behav. 2013, 38 (7): 2321-2324. 10.1016/j.addbeh.2013.03.002.CrossRefPubMed Lindqvist H, Forsberg LG, Forsberg L, Rosendahl I, Enebrink P, Helgason AR: Motivational Interviewing in an ordinary clinical setting: a controlled clinical trial at the Swedish National Tobacco Quitline. Addict Behav. 2013, 38 (7): 2321-2324. 10.1016/j.addbeh.2013.03.002.CrossRefPubMed
20.
go back to reference Segan CJ, Borland R: Does extended telephone callback counselling prevent smoking relapse?. Health Educ Res. 2011, 26 (2): 336-347. 10.1093/her/cyr009.CrossRefPubMed Segan CJ, Borland R: Does extended telephone callback counselling prevent smoking relapse?. Health Educ Res. 2011, 26 (2): 336-347. 10.1093/her/cyr009.CrossRefPubMed
21.
go back to reference An LC, Schillo BA, Kavanaugh AM, Lachter RB, Luxenberg MG, Wendling AH, Joseph AM: Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy. Tob Control. 2006, 15 (4): 286-293. 10.1136/tc.2005.014555.PubMedCentralCrossRefPubMed An LC, Schillo BA, Kavanaugh AM, Lachter RB, Luxenberg MG, Wendling AH, Joseph AM: Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy. Tob Control. 2006, 15 (4): 286-293. 10.1136/tc.2005.014555.PubMedCentralCrossRefPubMed
22.
go back to reference Carlin-Menter S, Cummings KM, Celestino P, Hyland A, Mahoney MC, Willett J, Juster HR: Does offering more support calls to smokers influence quit success?. J Public Health Manag Pract. 2011, 17 (3): E9-E15. 10.1097/PHH.0b013e318208e730.CrossRefPubMed Carlin-Menter S, Cummings KM, Celestino P, Hyland A, Mahoney MC, Willett J, Juster HR: Does offering more support calls to smokers influence quit success?. J Public Health Manag Pract. 2011, 17 (3): E9-E15. 10.1097/PHH.0b013e318208e730.CrossRefPubMed
23.
go back to reference Etter JF, Perneger T, Ronchi A: Distributions of smokers by stage: International comparison and association with smoking prevalence. Prev Med. 1997, 26: 580-585. 10.1006/pmed.1997.0179.CrossRefPubMed Etter JF, Perneger T, Ronchi A: Distributions of smokers by stage: International comparison and association with smoking prevalence. Prev Med. 1997, 26: 580-585. 10.1006/pmed.1997.0179.CrossRefPubMed
24.
go back to reference Pan W: Proactive telephone counseling as an adjunct to minimal intervention for smoking cessation: a meta-analysis. Health Educ Res. 2006, 21 (3): 416-427. 10.1093/her/cyl040.CrossRefPubMed Pan W: Proactive telephone counseling as an adjunct to minimal intervention for smoking cessation: a meta-analysis. Health Educ Res. 2006, 21 (3): 416-427. 10.1093/her/cyl040.CrossRefPubMed
25.
go back to reference Alberg AJ, Patnaik JL, May JW, Hoffman SC, Gitchelle J, Comstock GW, Helzlsouer KJ: Nicotine replacement therapy use among a cohort of smokers. J Addict Dis. 2005, 24 (1): 101-113. 10.1300/J069v24n01_09.CrossRefPubMed Alberg AJ, Patnaik JL, May JW, Hoffman SC, Gitchelle J, Comstock GW, Helzlsouer KJ: Nicotine replacement therapy use among a cohort of smokers. J Addict Dis. 2005, 24 (1): 101-113. 10.1300/J069v24n01_09.CrossRefPubMed
26.
go back to reference Alpert HR, Connolly GN, Biener L: A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tob Control. 2013, 22 (1): 32-37. 10.1136/tobaccocontrol-2011-050129.CrossRefPubMed Alpert HR, Connolly GN, Biener L: A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation. Tob Control. 2013, 22 (1): 32-37. 10.1136/tobaccocontrol-2011-050129.CrossRefPubMed
27.
go back to reference Gilljam H, Galanti R: Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden. Addiction. 2003, 98: 1183-1189. 10.1046/j.1360-0443.2003.00379.x.CrossRefPubMed Gilljam H, Galanti R: Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden. Addiction. 2003, 98: 1183-1189. 10.1046/j.1360-0443.2003.00379.x.CrossRefPubMed
28.
go back to reference Lund KE, Scheffels J, McNeill A: The association between use of snus and quit rates for smoking: results from seven Norwegian cross-sectional studies. Addiction. 2011, 106 (1): 162-167. 10.1111/j.1360-0443.2010.03122.x.PubMedCentralCrossRefPubMed Lund KE, Scheffels J, McNeill A: The association between use of snus and quit rates for smoking: results from seven Norwegian cross-sectional studies. Addiction. 2011, 106 (1): 162-167. 10.1111/j.1360-0443.2010.03122.x.PubMedCentralCrossRefPubMed
29.
go back to reference Fagerstrom K, Rutqvist LE, Hughes JR: Snus as a smoking cessation aid: a randomized placebo-controlled trial. Nicotine Tob Res. 2012, 14 (3): 306-312. 10.1093/ntr/ntr214.CrossRefPubMed Fagerstrom K, Rutqvist LE, Hughes JR: Snus as a smoking cessation aid: a randomized placebo-controlled trial. Nicotine Tob Res. 2012, 14 (3): 306-312. 10.1093/ntr/ntr214.CrossRefPubMed
30.
go back to reference Society for Research on Nicotine and Tobacco Subcommittee on Biochemical Verification: Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002, 4 (2): 149-159. 10.1080/14622200210123581.CrossRef Society for Research on Nicotine and Tobacco Subcommittee on Biochemical Verification: Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002, 4 (2): 149-159. 10.1080/14622200210123581.CrossRef
31.
go back to reference Tomson T, Bjornstrom C, Gilljam H, Helgason A: Are non-responders in a quitline evaluation more likely to be smokers?. BMC Public Health. 2005, 5 (1): 52-10.1186/1471-2458-5-52.PubMedCentralCrossRefPubMed Tomson T, Bjornstrom C, Gilljam H, Helgason A: Are non-responders in a quitline evaluation more likely to be smokers?. BMC Public Health. 2005, 5 (1): 52-10.1186/1471-2458-5-52.PubMedCentralCrossRefPubMed
Metadata
Title
Effectiveness of proactive and reactive services at the Swedish National Tobacco Quitline in a randomized trial
Authors
Eva Nohlert
John Öhrvik
Ásgeir R Helgason
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 1/2014
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/1617-9625-12-9

Other articles of this Issue 1/2014

Tobacco Induced Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.